{"id":22171,"date":"2021-09-16T12:00:00","date_gmt":"2021-09-16T12:00:00","guid":{"rendered":"https:\/\/celonpharma.com\/?p=22171"},"modified":"2021-09-16T12:00:00","modified_gmt":"2021-09-16T12:00:00","slug":"current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/","title":{"rendered":"Current report 40\/2021 \u2013 Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Date prepared: 09\/16\/2021&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Abbreviated name of the issuer: CELON PHARMA S.A.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Subject: Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical information<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Content of the report:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby announces that on 15 September 2021 the Management Board of the Warsaw Stock Exchange (\u201cGPW\u201d) has adopted a resolution concerning the admission and introduction of the Company\u2019s ordinary D-series bearer shares to stock exchange trading on the GPW Main Market List.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In its resolution, the Warsaw Stock Exchange Management Board stated that pursuant to \u00a7 19.1 and \u00a7 19.2 of the GPW Rules, 6,000,000 ordinary D-series bearer shares of the Company, having the nominal value of PLN 0.10 each, are admitted to stock exchange trading on the primary market.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">At the same time, the GPW Management Board decided to introduce the above-mentioned shares of the Company to trading on the primary market as of September 22, 2021, subject to the registration of these shares and designating them with the their \u201cPLCLNPH00015\u201d code by the Central Securities Depository of Poland on September 22, 2021.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby announces that on 15 September 2021 the Management Board of the Warsaw Stock Exchange (\u201cGPW\u201d) has adopted a resolution concerning the admission and introduction of the Company\u2019s ordinary D-series bearer shares to stock exchange trading on the GPW Main Market List.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[25],"tags":[],"class_list":["post-22171","post","type-post","status-publish","format-standard","hentry","category-current-report"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Current report 40\/2021 \u2013 Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Current report 40\/2021 \u2013 Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"The Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby announces that on 15 September 2021 the Management Board of the Warsaw Stock Exchange (\u201cGPW\u201d) has adopted a resolution concerning the admission and introduction of the Company\u2019s ordinary D-series bearer shares to stock exchange trading on the GPW Main Market List.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-16T12:00:00+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/\",\"url\":\"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/\",\"name\":\"Current report 40\/2021 \u2013 Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2021-09-16T12:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Current report 40\/2021 \u2013 Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Current report 40\/2021 \u2013 Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/","og_locale":"en_US","og_type":"article","og_title":"Current report 40\/2021 \u2013 Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading - CelonGROUP","og_description":"The Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby announces that on 15 September 2021 the Management Board of the Warsaw Stock Exchange (\u201cGPW\u201d) has adopted a resolution concerning the admission and introduction of the Company\u2019s ordinary D-series bearer shares to stock exchange trading on the GPW Main Market List.","og_url":"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/","og_site_name":"CelonGROUP","article_published_time":"2021-09-16T12:00:00+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/","url":"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/","name":"Current report 40\/2021 \u2013 Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2021-09-16T12:00:00+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celon.group\/en\/2021\/09\/16\/current-report-40-2021-admission-and-introduction-of-ordinary-d-series-bearer-shares-of-the-company-to-stock-exchange-trading\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Current report 40\/2021 \u2013 Admission and introduction of ordinary D-series bearer shares of the Company to stock exchange trading"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/22171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=22171"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/22171\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=22171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=22171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=22171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}